Skip to main content

Cyteir Therapeutics, Inc.

CYTDelisted Mar 18, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001662244

Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.

13F holders, Q2 2023

Institutional positions in Cyteir Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
+7 vs. Q1 2023
Shares held
16.0M
−1.03M (−6.1%) vs. Q1 2023
Total value
$41.7M
+$17.8M (+74.5%) vs. Q1 2023
New holders
12
7 more added
Sold out
5
8 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CYT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 39 institutions
Q1 2021: 0 institutionsQ2 2021: 33 institutionsQ3 2021: 38 institutionsQ4 2021: 48 institutionsQ1 2022: 52 institutionsQ2 2022: 45 institutionsQ3 2022: 37 institutionsQ4 2022: 30 institutionsQ1 2023: 32 institutionsQ2 2023: 39 institutionsQ3 2023: 41 institutionsQ4 2023: 38 institutionsQ1 2024: 4 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2023: $41.7M
Q1 2021: $0Q2 2021: $352.6MQ3 2021: $344.1MQ4 2021: $253.4MQ1 2022: $83.8MQ2 2022: $56.8MQ3 2022: $34.6MQ4 2022: $28.5MQ1 2023: $23.9MQ2 2023: $41.7MQ3 2023: $46.3MQ4 2023: $38.9MQ1 2024: $11.2MQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CYT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20244$11.2M
Q4 202338$38.9M
Q3 202341$46.3M
Q2 202339$41.7M
Q1 202332$23.9M
Q4 202230$28.5M
Q3 202237$34.6M
Q2 202245$56.8M
Q1 202252$83.8M
Q4 202148$253.4M
Q3 202138$344.1M
Q2 202133$352.6M
Q1 20210$0

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Cyteir Therapeutics, Inc.; share changes are against Q1 2023.

Institutions holding CYT in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Novo Holdings A/S3,662,636$9.52M0.74%−277,777−7.0%Reduced
BML Capital Management, LLC3,250,000$8.45M7.60%+103,704+3.3%Added
OUP Management Co., LLC2,459,572$6.39M10.91%00.0%Unchanged
Newtyn Management, LLC1,358,049$3.53M0.83%+405,102+42.5%Added
Anson Funds Management LP1,151,662$2.99M0.90%+1,151,662New
FMR LLC827,867$2.15M0.00%−1,424,464−63.2%Reduced
Vanguard Group Inc584,783$1.52M0.00%00.0%Unchanged
Western Standard LLC524,050$1.36M1.18%+524,050New
Laurion Capital Management LP359,500$934.7K0.04%00.0%Unchanged
Acuitas Investments, LLC329,173$855.9K0.50%+329,173New
Vazirani Asset Management LLC156,135$406.0K0.72%+156,135New
Evercore Wealth Management, LLC146,676$381.4K0.01%00.0%Unchanged
Aldebaran Capital, LLC143,739$373.7K0.38%−7,500−5.0%Reduced
Renaissance Technologies LLC139,800$363.0K0.00%−36,234−20.6%Reduced
Cantor Fitzgerald, L. P.132,096$343.4K0.01%+132,096New
Geode Capital Management, LLC119,032$309.5K0.00%00.0%Unchanged
RBF Capital, LLC117,295$305.0K0.02%00.0%Unchanged
BlackRock Inc.88,407$229.9K0.00%+7,161+8.8%Added
Bank of America Corp80,474$209.2K0.00%+12,935+19.2%Added
Marquette Asset Management, LLC67,990$176.8K0.04%00.0%Unchanged
CSS LLC60,454$157.2K0.01%+60,454New
Pale Fire Capital SE57,597$149.8K0.01%+57,597New
Caas Capital Management LP34,536$89.8K0.04%−115,870−77.0%Reduced
Two Sigma Advisers, LP25,900$67.3K0.00%−100−0.4%Reduced
State Street Corp23,853$62.0K0.00%00.0%Unchanged
Boston Family Office LLC24,197$62.0K0.00%+24,197New
Dimensional Fund Advisors LP21,064$54.8K0.00%+21,064New
Millennium Management LLC20,494$53.3K0.00%−63,282−75.5%Reduced
Northern Trust Corp18,984$49.4K0.00%00.0%Unchanged
Charles Schwab Investment Management Inc15,972$41.5K0.00%+15,972New
Morgan Stanley5,972$15.5K0.00%−119,231−95.2%Reduced
UBS Group AG5,267$13.7K0.00%+442+9.2%Added
FNY Investment Advisers, LLC5,297$13.0K0.02%+5,297New
Lindbrook Capital, LLC2,006$5.22K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)1,706$4.44K0.00%+1,706New
Royal Bank of Canada888$2.00K0.00%+885+29,500.0%Added
JPMorgan Chase & Co496$1.29K0.00%00.0%Unchanged
Federated Hermes, Inc.208$5410.00%00.0%Unchanged
Wells Fargo & Company102$2650.00%+4+4.1%Added
Avidity Partners Management LP0$00.00%−1,764,100−100.0%Sold out
Tang Capital Management LLC0$00.00%−100,000−100.0%Sold out
Bridgeway Capital Management, LLC0$00.00%−69,584−100.0%Sold out
EcoR1 Capital, LLC0$00.00%−43,823−100.0%Sold out
Cannell Capital LLC0$00.00%−19,684−100.0%Sold out